R ARIVANANTHAM
CHENNAI, MAR 20
In a significant push to reimagine diabetes care in India, MV Hospital for Diabetes has rolled out MVCON 2026, a three-day national conference bringing together the country’s foremost minds in diabetology, research, and clinical practice from Friday to Sunday – March 20 to 22.
MVCON 2026 #Chennai has turned out to be a rich academic feast, bringing together under one roof, leading experts from across India as well as international faculty.
The scientific programme includes hands-on workshops, clinical discussions, panel interactions,and research… pic.twitter.com/O5BBujv9FQ
— Dr Jitendra Singh (@DrJitendraSingh) March 20, 2026
- Three-day national summit in Chennai unites 100+ experts, 1,000 delegates
- Focus shifts from treatment to prevention of complications—kidney, eye, heart & diabetic foot
- Live workshops, cutting-edge tech & AI-driven care strategies take centre stage
- Prestigious orations & awards honour leaders shaping India’s diabetes landscape
- Multidisciplinary approach aims to redefine outcomes in Type 2 Diabetes care
With nearly 100 expert speakers and around 1,000 participants, the conference aims to spotlight the latest advances in managing Type 2 Diabetes—particularly its most debilitating complications affecting the kidney, eye, heart, and foot.
A key highlight is the strong emphasis on prevention over cure, especially in tackling diabetic foot disease—one of the most serious yet avoidable complications. Delegates are engaging in live, hands-on workshops covering debridement, advanced wound care, Negative Pressure Wound Therapy, imaging, and revascularisation techniques.
Prestige meets purpose
The event also celebrates excellence in healthcare and research through the MV Lifetime Achievement Awards, conferred upon:
- Jitendra Singh, noted diabetologist and Union Minister, for his outstanding contributions to diabetes research
- A. V. Anoop, Managing Director of AVA Group (Medimix), for advancing wellness and holistic healthcare practices
The conference also features the prestigious Prof. MV Gold Medal Oration 2026 by Ashok Kumar Das, a leading authority in endocrinology and academic medicine.
Voices that matter
Dr. Jitendra Singh, Union Minister & Diabetologist: “I feel deeply indebted to Tamil Nadu and extremely honoured to receive the MV Lifetime Achievement Award 2026. I encourage young professionals to contribute to advancements in research and patient care among people with diabetes.”
Dr. Viswanathan Vishnu Vijay, CEO, MV Hospital for Diabetes: “MVCON 2026 marks the first edition of MV’s annual scientific update. It has been conceptualised as a multidisciplinary platform that reflects the evolving nature of diabetes care. By bringing together different specialties, we aim to improve outcomes, particularly in preventing complications such as diabetic foot, which require coordinated and timely intervention.”
Read Also:
₹220 per shot, a health revolution: Eris unlocks next-gen diabetes care for millions
“A key focus of the conference is diabetic foot disease, one of the most serious yet preventable complications of diabetes. The scientific program emphasises a comprehensive approach, not only treating diabetes but actively preventing its complications through early intervention, advanced care, and coordinated clinical practice.”
“Experts will also explore the integration of AI and digital health, advanced therapeutics, and multidisciplinary care, with a focus on preventing complications rather than just treating diabetes.”
Science, scale & solutions
The scientific agenda is robust—featuring symposiums, panel discussions, debates, quizzes, and research presentations. Key themes include:
- Diabetic foot ulcer innovations
- Cardiovascular and renal complications
- Metabolic disorders, epigenetics & microbiota
- Diabetic Retinopathy technologies
- Chronic Kidney Disease in diabetes
- Gestational Diabetes
- Obesity and diabesity management
